| Malignant Salivary Gland Neoplasm studied in …STUDIED_INderived200 of 225show all (up to 200) |
|---|
| → studied in | NCT07667400Phase 1/Phase 2 · not yet recruiting Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07845097Phase 2 · not yet recruiting Phase II Trial Comparing Stereotactic Body Radiotherapy Versus Active Surveillance for Oligometastatic Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04858334Phase 2 · recruiting APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06781567Phase 2 · recruiting Clinical Trial of HG146 Administered to Participants With Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07162480Phase 2 · recruiting Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I) · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06462183Phase 1 · active not recruiting Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC) · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140526Phase 1/Phase 2 · active not recruiting Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815522Phase 2 · recruiting Abiraterone With Dalpiciclib in Salivary Gland Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05774899Phase 1/Phase 2 · recruiting CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00878163Phase 1 · active not recruiting GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04704661Phase 1 · active not recruiting Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00588770Phase 3 · active not recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02568267Phase 2 · active not recruiting Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04576091Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05408845Phase 2 · recruiting Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05286827Phase 2 · terminated Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Skin Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05010629Phase 2 · active not recruiting 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06891560Phase 2 · recruiting A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05669664Phase 2 · active not recruiting Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119453Phase 2 · terminated A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04657068Phase 1/Phase 2 · recruiting A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07522879Phase 2 · recruiting A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05075980Phase 2 · active not recruiting Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05884320Phase 2 · recruiting Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01365169NA · recruiting Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients" · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Major Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07521670Phase 2 · not yet recruiting Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03781986Phase 1/Phase 2 · active not recruiting APG-115 in Salivary Gland Cancer Trial · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03942653Phase 2 · active not recruiting Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06695845Phase 2 · recruiting A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07682675Phase 2 · not yet recruiting Study to Evaluate the Efficacy of Zanzalintinib in the Treatment of Relapsed or Metastatic Adenoid Cystic Carcinomas of the Head and Neck · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Salivary Gland Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05377996Phase 1/Phase 2 · recruiting A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04973683Phase 1 · completed AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06118086Phase 1/Phase 2 · recruiting Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07652489recruiting Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational Study · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04895735Phase 2 · active not recruiting MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02780310Phase 2 · active not recruiting Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07616141Phase 2 · not yet recruiting Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02757859NA · active not recruiting WASH Trial: Intraoperative Lavage as a Treatment for Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06054178Phase 2 · completed Identification of Nerves Using Fluorescein Sodium · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Parotid Gland Pleomorphic Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07320508Phase 2 · recruiting Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective Study · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07563088not yet recruiting SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05074940Phase 2 · active not recruiting Amivantamab in Adenoid Cystic Carcinoma · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00669734Phase 1 · active not recruiting Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04870762Phase 2 · recruiting Customized 3D Printed Oral Stents During Head and Neck Radiotherapy · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Malignant Parotid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04620187Phase 2 · recruiting Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05694819Phase 2 · completed Darolutamide in Patients With Androgen Receptor-Positive Salivary Gland Carcinoma (DISCOVARY) · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05483374recruiting The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05924256Phase 2 · active not recruiting A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular Typing · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06145308Phase 2 · recruiting Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07507578recruiting A Multi-omics Approach to Disclose Progression and Underlying Biology of Head and Neck Adenoid Cystic Carcinoma · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Salivary Gland Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07464366Phase 2 · recruiting The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: a Single-center, Open-label Cohort Study · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03360890Phase 2 · active not recruiting Pembrolizumab With Chemotherapy for Poorly Chemo-responsive Thyroid and Salivary Gland Tumors · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06464198recruiting Prospective Registry Study on the Implementation of Simultaneous Postoperative Radiochemotherapy for Salivary Gland Carcinomas of the Head and Neck Region · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00939627Phase 2 · completed Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02047474Phase 2 · completed Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01473784NA · recruiting Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Oral Cavity Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03740256Phase 1 · recruiting Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04150042Phase 1 · recruiting SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05553782early Phase 1 · recruiting Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06322576Phase 2 · terminated 177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05194072Phase 1 · terminated A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02069730NA · completed A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06115499Phase 2/Phase 3 · active not recruiting The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03172624Phase 2 · completed Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03556228Phase 1/Phase 2 · recruiting VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04209660Phase 2 · active not recruiting Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04883671NA · recruiting Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06805825Phase 1 · recruiting A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02628067Phase 2 · active not recruiting Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06521775Phase 2 · completed An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic Carcinoma · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02098538Phase 2 · completed Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00954226Phase 1 · completed Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06686979recruiting PDO Based Drug Sensitive Test in R/M SGC · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06582849NA · completed Enhanced Assistance During Radiotherapy for Unmet Essential Needs · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06535997completed Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILE · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06805617Phase 2 · recruiting A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06923826Phase 2 · recruiting Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC) · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072676NA · enrolling by invitation The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period. · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05513365Phase 2 · recruiting Phase II Dutasteride in Combination With CAB vs CAB in SDC · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02245100completed Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00405405Phase 1 · completed Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Parotid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02983279NA · completed Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Prostate Acinar Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04249947Phase 1 · terminated P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05733910NA · recruiting Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06199453Phase 2 · withdrawn The Evaluation of the Effectiveness, Safety and Tolerability of Treatment, Using a PSMA-Lu177, in Patients with ACC- an Open, Non-commercial Clinical Trial · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06778915completed Surgical Strategy for Head and Neck Adenoid Cystic Cancer · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01821612early Phase 1 · completed Chemotherapy and Radiation Therapy Before Surgery Followed by Gemcitabine in Treating Patients with Pancreatic Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028479completed The Registry of Oncology Outcomes Associated With Testing and Treatment · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02538510Phase 1/Phase 2 · completed Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01969578Phase 2 · completed Androgen Deprivation Therapy in Advanced Salivary Gland Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03990571Phase 2 · completed Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06091878unknown Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01847326Phase 1 · completed Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03924466Phase 2 · unknown Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03691207Phase 2 · completed A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03146650Phase 2 · unknown Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Major Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03422679Phase 1/Phase 2 · terminated Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03749460Phase 1/Phase 2 · completed Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214366Phase 2 · recruiting Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02178436Phase 1/Phase 2 · completed Gemcitabine, Nab-paclitaxel and KPT-330 in Advanced Pancreatic Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01703455Phase 2 · completed Activity of Sorafenib in Salivary Gland Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04706845completed Understanding the Burden of ACC Through the Eyes of Patients · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01586767NA · unknown Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602079Phase 1/Phase 2 · completed Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01835041Phase 1 · completed CPI-613 and Combination Chemotherapy in Treating Patients With Metastatic Pancreatic Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05898373Phase 1/Phase 2 · unknown Vedicitumomab Alone or in Combination for the Treatment of Locally Advanced or Metastatic SDC · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04291300Phase 2 · completed Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01332279Phase 1 · withdrawn Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04974866Phase 2 · unknown Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03886831Phase 1 · completed A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03287427Phase 1 · completed MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05727410Phase 2 · unknown Neoadjuvant Nivolumab, Docetaxel, Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade Salivary Gland Carcinoma · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Salivary Gland High Grade Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03999684Phase 2 · completed A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03032250NA · completed Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03087019Phase 2 · completed Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00981162Phase 1 · completed Sorafenib Tosylate and Everolimus in Treating Patients With Advanced Solid Tumors and Metastatic Pancreatic Cancer That Does Not Respond to Gemcitabine Hydrochloride · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214353NA · unknown PSMA-PET Imaging Before and After ADT in Advanced SDC Patients · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05499936NA · unknown 68Ga-FAPI PET/CT for the Detection of Adenoid Cystic Carcinoma(ACC) · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01924260Phase 1 · completed Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00470496Phase 1 · completed Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05390294completed Survival With Patients Treated With Salivary Gland Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04832438Phase 2 · withdrawn 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03132038Phase 2 · completed Nivolumab in Recurrent or Metastatic Salivary Gland Carcinoma of the Head and Neck · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03614364Phase 2 · unknown Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Duct Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03291002Phase 1 · unknown Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01816984Phase 1/Phase 2 · completed PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03942380NA · unknown Cell-free Tumor DNA in Head and Neck Cancer Patients · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03639168Phase 2 · completed Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC) · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05013515NA · unknown Efficacy and Safety of Neoadjuvant Surufatinib for Patients With Salivary Gland Carcinomas · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05008237Phase 2 · unknown Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01666730Phase 2 · completed Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031694Phase 2 · completed Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04801264early Phase 1 · unknown Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617 · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03729297Phase 2 · terminated Cabozantinib in Advanced Salivary Gland Cancer Patients · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04706052completed Facial Nerve Morbidity After Superficial Parotidectomy in the Absence of Nerve Conductor · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Pleomorphic Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01175980Phase 2 · completed Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Oral Cavity Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01249443Phase 1 · terminated Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03687294unknown Diagnostic Accuracy of Human Transcriptional Activator(MYB) Expression by ELISA Technique Versus Immmunohistochemistry in Detecting Salivary Gland Carcinomas · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02153450early Phase 1 · completed Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01643499Phase 1 · completed Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01344356Phase 4 · completed Stereotactic Body Radiotherapy for Head and Neck Tumors · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01044433Phase 2 · completed Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and Neck · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254617Phase 1 · completed Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01469429Phase 1/Phase 2 · completed Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416793Phase 2 · terminated Bortezomib and Carboplatin in Treating Patients With Metastatic Pancreatic Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02393820Phase 2 · completed Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01065844Phase 2 · completed Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01806675Phase 1/Phase 2 · completed 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02857712Phase 2 · completed Axitinib in R/M Salivary Gland Cancers of the Upper Aerodigestive Tract - SGC-AX14 · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01739439Phase 1 · terminated Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01604772Phase 2 · completed Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Oral Cavity Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02123511Phase 2 · completed Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01537107Phase 1 · completed Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01839981Phase 1 · completed CPI-613 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01770132Phase 1 · completed Ultrasound-Guided Photodynamic Therapy With Photofrin & Gemcitabine for Patients With Locally Advanced Pancreatic Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01524692Phase 2 · completed Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055913Phase 1/Phase 2 · completed Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Salivary Gland Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01613768Phase 2 · completed Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02942693Phase 2 · unknown Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02775370Phase 2 · unknown A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01164566NA · terminated Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Oral Cavity Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03319641NA · completed PSMA-PET Imaging for Advanced ACC/SDC · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02035527Phase 1 · completed Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00859937Phase 2 · completed Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01280058Phase 2 · completed Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01316757Phase 2 · completed Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01234935Phase 2 · completed Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01558661Phase 2 · completed Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00509002Phase 2 · completed Iressa Study in Patients With Salivary Gland Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883374Phase 2 · unknown Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and Safety · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02662608NA · completed Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC) · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095563Phase 2 · completed Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256385Phase 2 · completed Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00095628Phase 2 · completed SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02964351unknown microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Prostate Acinar Sarcomatoid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00581360Phase 2 · completed Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01283178Phase 1 · terminated Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01528137Phase 1 · terminated Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02048254Phase 3 · unknown Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01658943Phase 2 · completed Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Pancreatic Acinar Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01488838Phase 2 · completed A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00984217Phase 2 · withdrawn Trial of Radiotherapy and Panitumumab in Salivary Gland Malignancies · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Pleomorphic Adenoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01731379completed Optical Detection of Peripheral Nerve Bundles During Surgery · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Parotid Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02042885Phase 1/Phase 2 · terminated A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397384Phase 1 · completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01678105Phase 2 · completed A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00886132Phase 2 · completed A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01152840Phase 2 · completed Study of RAD001 in Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00458978Phase 2 · completed Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114283Phase 2 · completed Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02401763unknown Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis · condition mapped ALIAS · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01334177Phase 1 · completed TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Malignant Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01417143Phase 2 · completed Dovitinib in Adenoid Cystic Carcinoma · condition mapped ONTOLOGY_EXACT · 225 trials mapped (71 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01254734NA · terminated Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer · condition mapped CURATED_BROADER · 225 trials mapped (71 active) | — | — | Oral Cavity Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |